Characteristics | No (%)n = 90 |
---|---|
Mean age, years (SD) | 65 (9.88) |
Male Gender | 67 (74) |
ECOG PS | |
 0 | 34 (41) |
 1 | 33 (40) |
  > 2 | 15 (18) |
IMDC Risk Group | |
 Favorable | 12 (14) |
 Intermediate | 61 (69) |
 Poor | 15 (17) |
 Prior Nephrectomy | 67 (97) |
 No of prior systemic therapies, median, No. (range) | 2 (1, 6) |
No of prior systemic therapies | |
 1 | 42 (47) |
 2 | 24 (27) |
 3 | 16 (18) |
 4 | 6 (7) |
  > 5 | 2 (2) |
Most common prior systemic therapies | |
 Sunitinib | 64 (71) |
 Pazopanib | 30 (33) |
 Axitinib | 35 (39) |
Sites of metastases at baseline | |
 Brain | 14 (16) |
 Bones | 37 (41) |
 Lungs | 65 (72) |
 Liver | 27 (30) |
 Lymph Nodes | 58 (64) |
 Pleural | 18 (20) |
 Adrenal | 20 (22) |